| Company |
Product |
Therapeutic category |
Year of partnership |
| Alfa Wassermann, Italy |
Fluxum |
Cardiology |
1994 |
| Cimab |
IORT3 |
Nephrology |
1994 |
| Fujix Inc., Japan |
TripleACal |
Nutritional |
2004 |
| OM Pharma, Switzerland |
Broncho-Munal |
Respiratory |
2005 |
| Engelhard, Germany |
Prospan |
Respiratory |
2005 |
| New Collaborations |
|
|
|
| Sebapharma, Germany |
Sebamed |
Cosmeceuticals |
2006 |
| Kissei,
Japan |
Anti-diabetic |
Diabetes |
2006 |
Fluxum and Triple A Cal are marketed in India for more
than a year. We are the leaders in terms of units sales for Fluxum
and have maintained this leadership position from the launch year.
Triple A Cal is a specialized calcium and in just a year and a half,
we have reached No. 2 in terms of prescription generation. Prospan was launched in 2006 and we have sold more than 1.5 million bottles in 24months. Sebamed skin care range of products has been launched in 2007 and receives good reception.
Partner with USV for establishing Prime Position for your brand in the Indian pharmaceutical
market, contact us at bizdev@usv.co.in
|